Update on the Role of Antifibrinolytics in Patient Blood Management

Update on the Role of Antifibrinolytics in Patient Blood Management is organized by Advancing Transfusion and Cellular Therapies Worldwide and would be held on Nov 09, 2017. The target audience for this medical event for Physicians, Technologists, Nurses, Managers/Supervisors, Perfusionists, Medical Directors, Residents, Hospital Blood Banks.

Course description :-
This Course will describe the expanding use of antifibrinolytics in non-trauma surgical populations and review its effectiveness as a patient blood management strategy. Antifibrinolytic therapy has been used for years in cardiac surgery and liver transplantation where the risk of bleeding is high. More recently, its role as a blood conservation strategy has become common practice in joint replacement procedures, resulting in a dramatic decline in blood transfusion requirements in these surgical patients. Likewise, reports of the use of antifibrinoltyics in complex spine surgery and other neurosurgical procedures has reduced bleeding and the need for transfusions.

Conference Objectives are :
• Describe the currently available antifibrinolytics and their role in hemostasis and reducing surgical blood loss.
• Review the growing use of antifibrinolytics in various non-trauma surgical populations.
• Discuss the impact perioperative use of antifibrinolytics has on reducing blood transfusions

Additional details will be posted as soon as they are available.